WallStreetZenWallStreetZen

NASDAQ: MNPR
Monopar Therapeutics Earnings & Revenue

MNPR earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$7.6M
Current Profit Margin
0%

MNPR Return on Equity

Current Company
-110.6%
Current Industry
16.8%
Current Market
28.2%
MNPR's Return on Equity (-110.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MNPR announces earnings.

MNPR Return on Assets

Current Company
-86.5%
Current Industry
3.2%
MNPR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MNPR Return on Capital Employed

Current Company
-101.76%
Current Industry
-42.4%
MNPR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MNPR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MNPR$0.00-$7.61M-$7.61MN/AN/A
AVTX$1.45M-$140.24M-$142.88M-22.31%N/A
IMNN$0.00-$19.39M-$18.85M-100.00%N/A
KPRX$16.00M$2.95M$2.28M+37.61%N/A
LUMO$1.53M-$37.12M-$37.13M-9.94%N/A

MNPR earnings dates

Next earnings date
Aug 8, 2024

Monopar Therapeutics Earnings & Revenue FAQ

What were MNPR's earnings last quarter?

On Invalid Date, Monopar Therapeutics (NASDAQ: MNPR) reported Q1 2024 earnings per share (EPS) of -$0.10, up 47.37% year over year. Total Monopar Therapeutics earnings for the quarter were -$1.64 million. In the same quarter last year, Monopar Therapeutics's earnings per share (EPS) was -$0.19.

If you're new to stock investing, here's how to buy Monopar Therapeutics stock.

What was MNPR's earnings growth in the past year?

As of Q3 2024, Monopar Therapeutics's earnings has grown year over year. Monopar Therapeutics's earnings in the past year totalled -$7.61 million.

What is MNPR's earnings date?

Monopar Therapeutics's earnings date is Invalid Date. Add MNPR to your watchlist to be reminded of MNPR's next earnings announcement.

What was MNPR's revenue last quarter?

On Invalid Date, Monopar Therapeutics (NASDAQ: MNPR) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Monopar Therapeutics's revenue was $0.00.

What was MNPR's revenue growth in the past year?

As of Q3 2024, Monopar Therapeutics's revenue has grown null year over year. Monopar Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.